NPR Online News

Dozens of states sue to block the sale of 23andMe personal genetic data

<span>Regeneron Pharmaceuticals announced plans to acquire 23andMe for $256 million, with the deal requiring court approval and facing scrutiny from a court-appointed consumer privacy ombudsman who must report findings by Tuesday.</span

Regeneron Pharmaceuticals announced plans to acquire 23andMe for $256 million, with the deal requiring court approval and facing scrutiny from a court-appointed consumer privacy ombudsman who must report findings by Tuesday.

<span>The lawsuit argues that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without each person's express, informed consent, with Oregon Attorney General Dan Rayfield stating the data "cannot be sold like ordinary property.".</span

NBC10 Philadelphia

ConsumerAffairs

The lawsuit argues that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without each person's express, informed consent, with Oregon Attorney General Dan Rayfield stating the data "cannot be sold like ordinary property.".

<span>23andMe filed for Chapter 11 bankruptcy protection in March after struggling financially since going public in 2021, laying off 40% of its staff and raising concerns about the safety of customer data from more than 15 million users.</span

Ibtimes

23andMe filed for Chapter 11 bankruptcy protection in March after struggling financially since going public in 2021, laying off 40% of its staff and raising concerns about the safety of customer data from more than 15 million users.

<span>The company previously suffered a major data breach in 2023 that affected nearly 7 million customers, with hackers leaking personal data including origin estimation, phenotype, health information, photos and identification data on online forums.</span

Quartz

The company previously suffered a major data breach in 2023 that affected nearly 7 million customers, with hackers leaking personal data including origin estimation, phenotype, health information, photos and identification data on online forums.

<span>Regeneron has stated it will comply with 23andMe's existing privacy policies and applicable law, processing customer data in accordance with current consents, privacy policies, terms of service and notices while maintaining security controls to protect the information.</span

Regeneron has stated it will comply with 23andMe's existing privacy policies and applicable law, processing customer data in accordance with current consents, privacy policies, terms of service and notices while maintaining security controls to protect the information.

NPR Online News #1

<h2></h2>

Genetics & heredity

Privacy

United States of America

Regeneron has committed to honoring all existing privacy agreements and maintaining robust security protections for customer data. The acquisition could actually strengthen data security by placing genetic information under the control of an established pharmaceutical company with proven compliance capabilities.

<span>Regeneron has committed to honoring all existing privacy agreements and maintaining robust security protections for customer data. The acquisition could actually strengthen data security by placing genetic information under the control of an established pharmaceutical company with proven compliance capabilities.</span>

27 States Sue to Block 23andMe DNA Data Sale Without Consent

Dozens27 ofStates statesSue sue to blockBlock the23andMe saleDNA ofData 23andMeSale personalWithout genetic dataConsent

The Spin

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

27 States Sue to Block 23andMe DNA Data Sale Without Consent

Dozens27 ofStates statesSue sue to blockBlock the23andMe saleDNA ofData 23andMeSale personalWithout genetic dataConsent

The Spin

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters